Canada markets closed

Defence Therapeutics Inc. (DTC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
2.0000+0.0800 (+4.17%)
At close: 03:59PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 86.47M
Enterprise Value 86.76M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)89.80
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -12.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.53
52-Week Change 3-49.61%
S&P500 52-Week Change 326.89%
52 Week High 33.9600
52 Week Low 31.6600
50-Day Moving Average 32.0712
200-Day Moving Average 32.5689

Share Statistics

Avg Vol (3 month) 320.62k
Avg Vol (10 day) 315.33k
Shares Outstanding 544.87M
Implied Shares Outstanding 645.04M
Float 841.83M
% Held by Insiders 14.77%
% Held by Institutions 10.00%
Shares Short (Jan 15, 2024) 410.66k
Short Ratio (Jan 15, 2024) 40.19
Short % of Float (Jan 15, 2024) 4N/A
Short % of Shares Outstanding (Jan 15, 2024) 40.02%
Shares Short (prior month Dec 15, 2023) 445.96k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Sept 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-459.81%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-7.26M
Diluted EPS (ttm)-0.1900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.35M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)1.64M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.82
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-7.55M
Levered Free Cash Flow (ttm)-5.18M